FDA.reportPublic FDA data

Arakoda 100 MG Oral Tablet

RxCUI
2054102
RxNorm name
Arakoda 100 MG Oral Tablet
Display name
Arakoda 100 MG Oral Tablet
Full name
Arakoda 100 MG Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:51

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ArakodaTAFENOQUINE60 Degrees Pharmaceuticals, INC.299e49d8-470f-4779-a010-4a1ee0e0c6cd2025-01-10Warnings, Adverse reactionsExact identifier
rxcui: 2054102

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
299e49d8-470f-4779-a010-4a1ee0e0c6cdArakoda 100 MG Oral Tablet [PSN] · tafenoquine 100 MG Oral Tablet [Arakoda] [SBD] · Arakoda 100 MG Oral Tablet [SY]36These highlights do not include all the information needed to use ARAKODA™ safely and effectively. See full prescribing information for ARAKODA™. ARAKODA™ (tafenoquine) tablets, for oral use Initial U.S. Approval: 201820250110